David P. ROYE, Jr., MD
President and Chief Executive Officer, International Healthcare
Leadership
Dr. Roye is one of the world’s leading pediatric orthopaedic surgeons, and has
spent decades providing care to children around the world. He is Chief of
Pediatric Orthopaedic Surgery at the New York-Presbyterian Morgan Stanley
Children’s Hospital, and St. Giles Professor of Pediatric Orthopaedic Surgery at
the Columbia University College of Physicians and Surgeons.
Dr. Roye’s volunteer work has taken him to Africa, Eastern Europe and to
China. For the past twelve years, Dr. Roye has served as Chief Medical Officer
of the Children of China Pediatrics Foundation, a not-for-profit organization
that sends pediatric medical teams from the United States to China to provide
medical education and perform surgeries on orphans to correct disfiguring
birth defects and disabilities. In 2009 the American Association of Orthopaedic
Surgeons honored Dr. Roye with the Humanitarian of the Year Award. Dr. Roye
has recently been awarded faculty privileges at the Beijing Children’s Hospital.
Aware of the challenges facing healthcare reform in China, Dr. Roye founded
International Healthcare Leadership (IHL). A non-profit organization, IHL
designs and implements educational programs in health care management
and policy for government officials and health care executives in China. By
offering the annual course on campuses in the United States, IHL works to
strengthen relationships between American and international health care
leaders.
骆德唯，医学博士
国际健康领导者协会（IHL）主席及首席执行官
骆德唯医生是世界顶尖的儿科骨科医生。几十年来，他为世界各地
的儿童提供医疗服务。他是纽约摩根士丹利儿童医院骨科主任，也
是哥伦比亚大学内科与外科学院儿科骨科学St. Giles教授。
骆德唯医生在非洲，东欧以及中国开展志愿者工作。在过去的十
多年里，他一直担任中国儿科医疗基金会（CCPF）的医疗总监。
中国儿科医疗基金会是是一个非营利性组织，它派遣美国的儿科医
疗队伍到中国，为中国的医生提供医学教育并为中国孤儿实施手术
以帮助矫正其先天性的缺陷与残疾。去年，美国骨科学会为骆德唯
医生颁发了“年度人道主义大奖”。骆德唯医生最近还获得了在北
京儿童医院的行医资格。
在意识到中国所面临的医疗改革的挑战之后，骆德唯医生创办了
国际医疗保健领导协会（IHL）。IHL是一个非营利组织，其目的
是针对新兴国家的政府官员以及医疗卫生管理者设计和讲授医疗卫
生管理课程。通过每年一次的在美国进行的课程教学，IHL致力于
加强美国与国际医疗卫生领导者的联系。
Professor Geng XIAO, PhD
Director, Columbia Global Centers (East Asia﹒Beijing)
Professor Geng Xiao is Director of Columbia Global Centers (East
Asia﹒Beijing), established by the Columbia University. He is also an
Honorary Professor at the University of Hong Kong, an Independent
Director of the HSBC Bank (China) and the Genesis Emerging Markets
Fund. Previously Professor Xiao was the founding Director of the
Brookings-Tsinghua Center for Public Policy in Beijing, a Senior Fellow at
the Brookings Institution, a tenured professor of economics at the
University of Hong Kong, Head of Research and Advisor to the Chairman
at the Securities and Futures Commission of Hong Kong, Vice President
of the Chinese Economists Society in the US, a member of the board of
supervisors at the Shenzhen Development Bank, a Faculty Associate at
Harvard University, and a Consultant at the World Bank.
Geng obtained his BSc in Management Sciences from the University of
Science and Technology of China and his MA & PhD in Economics from
UCLA. Professor Xiao has done extensive empirical and policy research
on the Chinese economy, especially in areas of enterprise,
macroeconomics, exchange rate, finance, and institutional economics,
providing provocative, timely and useful policy analysis and
recommendations. He also contributes frequently to public policy
debates through media presences and conference presentations.
肖耿 教授，博士
哥伦比亚大学全球中心（东亚•北京）主任
肖耿教授现任哥伦比亚大学全球中心（东亚•北京）主任、香港
大学荣誉教授、汇丰银行（中国）以及英国Genesis新兴市场基
金公司（GEMF）独立董事。曾任清华-布鲁金斯公共政策研究中
心首任主任、美国布鲁金斯学会资深研究员、香港大学经济学
终身教授、香港证监会研究部主管及主席顾问、中国留美经济
学会副会长、深圳发展银行监事会监事、哈佛大学兼职研究员、
及世界银行顾问。
肖耿拥有中国科技大学管理科学学士及加州大学洛杉矶分校经
济学硕士及博士。肖教授的研究涉及中国经济的实证研究与政
策分析，特别在企业、宏观经济、汇率、金融及制度经济学领
域，提出过很多富有创意、及时且有效的分析和建议。肖教授
也通过媒体及会议积极参与公共政策辩论。
Lan XUE, PhD
Professor and Dean, School of Public Policy and Management;
Executive Vice President, Development Research Academy for the 21st
Century; Director of China Institute for Science and Technology Policy,
Tsinghua University
Dr. Lan Xue is professor and Dean of the School of Public Policy and
Management, Executive Vice President of the Development Research Academy for
the 21st Century, and Director of China Institute for Science and Technology Policy
at Tsinghua University. He is also an adjunct professor at Carnegie Mellon
University. His teaching and research interests include public policy analysis and
management, science and technology policy, higher education policy, and crisis
management.
Dr. Xue has consulted for the World Bank, IDRC，APEC and other international
organizations. He was the Chair of the Task Force for APEC 1998 Economic Outlook
Report from 1997 to 1998. He is on the advisory board of many government
agencies in China. In April 2003, he was invited to give a lecture to the top Chinese
leadership on the issue of S&T Policy. Dr. Xue currently serves as a Vice President of
China Association of Public Administration, Vice President of Chinese Association of
Science of Science and S&T Policy, Vice Chairman of the National Steering
Committee for MPA Education. He is also a member of the Visiting Committee for
Kennedy School of Government at Harvard University and on the Board of Trustees
of SciDev.Net.
Trained as an engineer, Dr. Xue has a Ph.D. in Engineering and Public Policy
from Carnegie Mellon University and taught at the George Washington University
before returning back to China. He is a recipient of 2001 National Distinguished
Young Scientist Award in China.
薛澜，博士
清华大学公共管理学院教授兼院长，清华大学21
世纪发展研究院常务副院长，清华大学中国科技政
策研究中心主任
清华大学公共管理学院教授兼院长，清华大学21世纪发展研
究院常务副院长，清华大学中国科技政策研究中心主任，清华大
学学术委员会副主任。薛澜1991年获美国卡内基梅隆大学工程与
公共政策博士学位后受聘担任美国乔治华盛顿大学助理教授。
1996年回国任教于清华大学。主要研究方向为公共政策与管理、
科技政策与创新管理、危机管理等。曾获清华大学学术新人奖，
良师益友奖，优秀教学成果一等奖，国家自然科学基金委员会杰
出青年基金奖，长江学者特聘教授等。他还兼任中国行政管理学
会副会长、科学学与科技政策研究会副理事长、中国管理科学学
会副会长，国务院应急管理专家组成员，全国MPA教育指导委员
会副主任委员、国际发展研究中心（IDRC）董事、哈佛大学肯尼
迪政府学院顾问委员会委员、世界经济论坛全球行动委员会巨灾
委员会副主席、国际风险治理学会学术委员会委员，卡内基梅隆
大学兼职教授等。
Professor Guoen LIU, PhD
Professor of Economics and Executive Director for The Health
Economics and Management Institute (HEMI), Peking University
Guanghua School of Management; and Director of the PKU Center for
Health Economic Research
Prior to Peking University, Dr. Liu served as tenured associate professor at University
of North Carolina at Chapel Hill (2000 – 2006); and assistant professor at the
University of Southern California (1994 – 2000). He received his PhD in economics
from the City University of New York Graduate Center in 1991, and post-doctoral
training in health economics from Harvard University in 1994.
Dr. Liu currently serves on the State Advisory Council for Health Reform, the State
Ministry of Human Resources and Social Security, and the State Ministry of Health
Commission for Emergent Public Health. He also chairs the Expert Panel for the
Chengdu Municipal Government Health Reform Taskforce, the Chinese Society for
Pharmacoeconomics and Outcomes Research. He was the 2005-2006 President of
the Chinese Economists Society (www.China-CES.org), and the founding chair of
Asian Consortium for the International Society for Pharmacoeconomics and
Outcomes Research (www.ISPOR.org).
Dr. Liu serves as Co-Editor for the ISPOR official journal of Value in Health, Editor-inChief for the China Journal of Pharmaceutical Economics; and on the editorial board
for Global Handbook of Health Economics, Chinese Journal of Health Economics,
and European Health Economic Review. His primary research interests include
health and development economics, health policy reform, and pharmaceutical
economics. Dr. Liu’s current research projects are funded by the National Science
Foundation, NIH, UNICEF, World Bank, and the State Council Expert Panel on the
Urban Resident BMI.
刘国恩 教授，博士
北京大学应用经济学教授；北京大学卫生经济研究所
执行主任；中国药物经济学与效用研究中心主任
刘国恩博士 – 北京大学光华管理学院经济学教授，北大光华卫生经
济与管理研究院执行院长，北京大学中国卫生经济研究中心主任，
博生导师。刘国恩教授曾执教美国南加利福尼亚大学（1995-1999
）；美国北卡大学（2000- 终身教职）；中国留美经济学会20042005届主席；以及国际医药经济学会亚太联合会主席。
在国家政策咨询方面，刘国恩教授担任国务院国家医改专家咨询委
员会委员，国务院城镇居民医疗保险试点评估专家组成员，国家人
力资源与社会保障部专家委员会委员，国家卫生部突发公共卫生事
件专家委员会委员，成都市人民政府医改专家组组长等职。
在学术研究领域，刘国恩教授担任中国药物经济学专业委员会主任
委员，国际药物经济学会官方期刊《Value in Health》副主编，《
中国药物经济学》杂志主编，以及《Global Handbook of Health
Economics》，《European Health Economic Review》编委等。刘国
恩教授的研究方向为健康与发展经济学，医疗体制改革，以及医药
经济学。
Lisa SAIMAN, MD, MPH
Professor of Clinical Pediatrics, Columbia University Medical
Center; Hospital Epidemiologist, NewYork-Presbyterian
Morgan Stanley Children's Hospital
Dr. Lisa Saiman received her medical degree from Albert Einstein
College of Medicine in the Bronx, New York. She performed her
pediatric residency and subspecialty training in pediatric infectious
diseases at Columbia University. She joined the Department of
Pediatrics at Columbia University in 1989 and received her Masters
of Public Health in Epidemiology from Columbia University in 1999. Dr.
Saiman is currently Professor of Clinical Pediatrics in the Department
of Pediatrics at Columbia University and the Hospital Epidemiologist
at NewYork-Presbyterian Morgan Stanley Children’s Hospital.
Dr. Saiman’s primary research and clinical interests are in cystic
fibrosis (CF), healthcare-acquired infections, multidrug-resistant
pathogens, and antimicrobial stewardship. She is the principal
investigator of her divisions T-32 fellowship training grant in pediatric
infectious diseases. She has served as a division chair for the
American Society of Microbiology and serves on the Editorial Board
of the journals Infection Control and Hospital Epidemiology and the
Archives of Pediatric & Adolescent Medicine.
Lisa SAIMAN，医学博士，公共卫生硕士
哥伦比亚大学医学中心临床儿科学教授，纽约长
老会摩根士丹利儿童医院流行病学家
Lisa Saiman 医生从纽约布朗克斯的爱因斯坦医学院获得医学
学位。她在哥伦比亚大学医学院完成了住院医师培训，并在
此进行儿科传染病专科培训。 她于1989年进入哥伦比亚大学
儿科系，并于1999年获得哥伦比亚大学流行病学公共卫生硕
士学位。 Saiman博士目前在哥伦比亚大学儿科部担任临床儿
科教授，并且是纽约长老会摩根士丹利儿童医院的流行病学
家。
Saiman博士的主要研究方向是囊性纤维化（CF）、医疗感染、
多药耐药病原体以及抗生素监管。她是儿科传染病方面的T-32
研究培训基金的主要负责人。她曾担任美国微生物学会的分
部主席 ，并担任期刊《感染控制 和医院流行病学》和《儿科
和青少年医学档案》的编委会成员。
Katharina JANUS, PhD, MBA
Professor of Healthcare Management at Ulm University,
Germany, and the Director of the Center for Healthcare
Management, a global research network
Professor Janus also holds appointments at Columbia University’s
department of health policy and management and at the University of
California, Berkeley.
Prof. Janus focuses her research on the design and implementation of
monetary and non-monetary incentive systems in healthcare
organizations in order to support decision-making of healthcare
professionals in complex situations and to change their behavior. Based
on theories of organizational psychology Prof. Janus implements
postmodern leadership structures in order to create learning systems,
thereby reducing medical errors. She has been the principal
investigator of several international studies on physician motivation
and professional culture in collaboration with the Hannover Medical
School, the University of California at Berkeley and Stanford University,
USA. Additionally, Prof. Janus has been involved in political advisory
councils and managed care projects on a national and international
level.
Born in Eutin (Northern Germany) in 1975, Dr. Janus earned her
Master's Degree in Business Administration at the University of
Hamburg and the Université Panthéon-Sorbonne Paris in 2000. She
holds a PhD in Business and Social Sciences from Helmut-SchmidtUniversity in Hamburg (2003). Dr. Janus was a 2006-07 Harkness Fellow
in Health Care Policy at The Commonwealth Fund.
Katharina JANUS，博士，
工商管理硕士
德国乌尔姆大学医疗管理教授，医疗管理中心（一个
全球研究网络）主任， 她也在哥伦比亚大学卫生政策
部门以及加州大学伯克利分校任职
Janus 教授的研究主要关注在医疗机构实施金钱和非金钱的激励
制度 ，其目的是为了支持医护专业人员在复杂情况下的决策制定
并且影响他们的行为。为了创建学习系统，Janus 教授根据组织
心理学理论，实施了后现代的权利和领导结构，从而减少了医疗
差错。她与美国的汉诺威医学院、加州大学伯克利分校以及斯坦
福大学合作进行研究，是几个关于医生积极性和专业文化的国际
研究项目的主要研究员。此外，Janus教授曾在政治顾问委员会任
职，并参与了几个国家级和国际级的卫生项目。
Janus博士于1975年在Eutin（德国北部）出生，于2000年在汉堡
大学以及巴黎一大获得了工商管理硕士学位。2003年，她从德国
汉堡的赫尔姆特•施密特大学获得了商业和社会科学博士学位。
Janus 博士是2006-07年度联邦基金会医疗政策研究员。
Professor Xiaoqing ZHOU
Director of Pharmacy, Professor, Former Director
of the PLA General Hospital, Director of Pharmacy
Division
Professor Zhou is currently a member of the Chinese
Pharmaceutical Association, deputy Secretary of Chinese
Licensed Pharmacist Association, deputy editor of the
“Chinese Licensed Pharmacist” Magazine, and a
member of the editorial board of several professional
journals.
Professor Zhou is the chief editor of 21 medical books,
author of more than 100 articles, winner of nine Science
and Technology Progress Awards for medical
achievements in “Post-Antibiotic Effect Series of Excellent
Research and Administration Program” and in the “Study
of Drugs: Quality Control Methodology.”
周筱青 教授
主任药师、教授；原解放军总医院药材处处
长；主任药师
周筱青教授现任卫生部合理用药专家委员会委员、
中国药学会理事、中国执业药师协会副秘书长、
《中国执业药师》杂志副主编，并担任多种专业刊
物编委。
她曾主编、参编学术著作21部，发表学术论文100
余篇，获军队科技进步奖、医疗成果奖9项。代表
性成果包括《抗生素后效应系列研究与给药方案优
化》，《药品、制剂质量控制方法学的研究》 等。
Li YANG, PhD
Ph.D., Associate Professor and Master Instructor of School
of Public Health, Health Policy and Management at Peking
University Health Science Center
Dr. Li Yang graduated in 1999 from Huaxi Medical University with a Master
of Science. In 2004, Yang graduated from Fudan University with a Ph.D. in
Management. Yang also received a postdoctoral degree in 2009 from
University of Vienna, Austria and was a visiting scholar at Harvard Medical
School in 2011.
Dr. Yang is a member of the International Health Economics Association, and
the International Society of Pharmacoeconomics and Outcome Research
(ISPOR) of Asia Pacific area. She serves as the Editor for the China Journal of
Pharmaceutical Economics and the Chinese Practice of Pharmacist and Drug
Evaluation. Her primary research interests include pharmaceutical
economics, drug policy, the economic impact of chronic diseases,
intervention strategies, health economics and health policy reform.
Dr. Yang presided over the “Basic Policy Research related to Drug
Production,” the “Pricing Mechanism for Essential drugs and impact,” and
the "Evaluation of Policy on Essential Drugs Based on the New Rural
Cooperative Medical System." These research projects were funded by the
National Natural Science Foundation, China’s Ministry of Health and
Ministry of Education.
杨莉，博士
博士，北京大学医学部公共卫生学院卫生政策与
管理系副教授、硕士生导师
杨莉博士于1999年毕业于华西医科大学（现四川大学华西医学
中心），获硕士学位；2004年毕业于复旦大学，获管理学博士
学位。2009年在奥地利维也纳大学进行博士后研究。2011年在
哈佛大学医学院担任访问学者。
杨莉博士是国际卫生经济学会会员，国际药物经济学与结果研
究学会(ISPOR)亚太组委会成员，并且担任中国药物经济学、中
国执业药师、药品评价等杂志的编委。她的主要研究方向为：
药物经济学和药品政策、慢性病经济影响及干预策略、卫生经
济与卫生改革研究。
她曾主持了 “基本药物生产相关政策研究”、“定价机制对基
本药物提供和使用的影响”、“基于新农合的基本药物制度实
施效果评价研究”等由国家自然科学基金、卫生部、教育部资
助的十多项科研课题。她还参与了北京大学“国家医改建议方
案研究”、“中国中老年人健康和养老调查”、“健康中国
2020”、“抗生素滥用的公共安全研究”、“基本药物制度监测
与评价可持续研究”等由国际组织、科协、各部委委托的重大
项目研究。
Professor Didier PITTET, MD, MS, CBE
Hospital Epidemiologist and Director of the Infection Control
Programme and WHO Collaborating Centre on Patient Safety at the
University of Geneva Hospitals; Faculty of Medicine, Geneva,
Switzerland; Professor of Medicine and Hospital Epidemiology,
University of Geneva
He holds Honorary Professorships at Imperial College London, UK, the Faculty of
Health and Social Sciences, Hong Kong Polytechnic University School of Health
Science, and the First Medical School of the Fu, Shanghai, China. Professor Pittet
is Lead of the World Health Organization First Global Patient Safety Challenge
“Clean Care is Safe Care”. He is the recipient of several national and international
honours including a CBE (Commander of the British Empire) awarded by Her
Majesty Queen Elisabeth II for services to the prevention of healthcareassociated infection in the UK (2007), the Society for Healthcare Epidemiology of
America Lectureship for his contribution to infection control and healthcare
epidemiology (2008), and the European Society of Clinical Microbiology and
Infectious Diseases’ Award for Excellence (2009). Professor Pittet is co-author of
more than 400 publications in peer-reviewed journals and 50 chapters in
textbooks; his current research interests include the epidemiology and
prevention of healthcare-associated infections, methods for improving
compliance with barrier precautions and hand hygiene practices, as well as
innovative methods for improving the quality of patient care and patient safety.
He is also involved in research on the epidemiology of infectious diseases. The
experience of his team in engaging nations and healthcare settings worldwide in
a universal commitment to patient safety is unique.
Professor Didier PITTET，医学博士，
理学硕士，大英帝国勋章获得者
日内瓦大学流行病学家、控制感染项目主任、世界卫
生组织患者安全合作中心主任；瑞士日内瓦大学医学
院医学教授
Pittet是英国伦敦帝国学院医疗及社会科学院、香港理工大学健
康科学学院、复旦大学医学院名誉教授。 Pittet教授是世界卫
生组织第一全球患者安全项目“清洁的护理是安全的护理”的
领导者。 他多次获得国家级和国际级荣誉，包括英女皇伊丽莎
白二世颁发的大英帝国勋章，以表彰其在防止医疗感染上作出
的贡献（ 2007）；美国流行病学讲师医疗协会的奖章，表彰其
在感染控制和医疗保健流行病学方面的贡献（2008）；以及欧
洲协会临床微生物学和传染病优秀奖（2009）。 Pittet教授是
在评审期刊发表的400余篇论文的合著者，也合作编写过50余
章教科书。他目前的研究方向包括：流行病和医疗感染的预防
，改善隔离预防和手部消毒的方法，提高病人护理质量和病人
安全。
Paul CHANG, MBBS, MPH, CPHQ, FACHE
.
Managing Director, Joint Commission International,
Asia Pacific Office
In this capacity, Dr. Paul Chang is responsible for furthering the
development of relationships between JCI and Asia-Pacific health care
organizations and works with regional Ministries of Health, other
governmental agencies, NGOs, hospitals, laboratories and other health
care organizations in their efforts to reduce risk and improve health
outcomes.
Prior to this, Dr. Chang was overseeing clinical quality, risk management,
quality improvement and JCI accreditation in Changi General Hospital,
an 800 bed Singaporean public hospital, and was part of the
management team that led the hospital to achieve JCI accreditation in
June 2005 as well as JCI Disease specific certification in 2 Cardiology
programs – Acute Myocardial Infarct management and Heart Failure
Management - in January 2007. Dr. Chang also has working experience
in both the Singapore Ministry of Health and in various Singapore
hospitals.
Dr. Chang earned his medical degree and his Masters in Public Health
from the National University of Singapore. He is a Certified Professional
in Healthcare Quality and is also a trained JCI accreditation surveyor.
Paul CHANG，内外全科医学士，公共
卫生硕士，CPHQ，FACHE
.
国际联合委员会亚太地区办事处 董事总经理
Paul CHANG医生目前的职责包括促进国际医院管理标准
(JCI)和亚太地区医疗保健机构间的关系发展；并与区域卫
生部、其他政府机构、非政府组织、医院、实验室和其
他医疗保健机构合作，降低医疗风险并改善医疗状况。
在此之前，Paul CHANG医生在新加坡樟宜综合医院（一
间拥有800个床位的公立医院）工作，负责监督临床质量，
风险管理，质量改进和JCI评审。在他所在的管理团队的
领导下，医院在2005年6月通过了国际医院管理标准评审。
2007年1月，医院的两个跟心脏有关的研究项目——急性
心肌梗死治疗和心力衰竭治疗——获得了JCI的疾病特殊
认证。Chang医生还拥有在新加坡卫生部和新加坡多家医
院工作的经验。
Chang医生在新加坡国立大学获得公共卫生硕士学位，获
得过专业医疗质量认证，并且是受过专业培训的JCI评审
员。
Peter MUENNIG, MD, MPH
Associate Professor, Mailman School of Public
Health, Columbia University
Peter Muennig has also worked as a consultant for the
Centers for Disease Control and Prevention and the
Canadian government, on multiple international projects,
and he founded the Burmese Refugee Project, an NGO in
Northern Thailand. His primary area of research interest
is in the evaluation of the health effects of major social
policies, such as early childhood interventions, lead
control, housing, and community enhancements. He has
been published over 50 research papers and has
authored two textbooks. His work has appeared on NPR,
CNN, MSNBC and multiple times in major print media
sources, such as the New York Times and Slate.
Peter MUENNIG，医学博士，
共卫生硕士
哥伦比亚大学公共卫生学院副教授
Peter Muennig 是哥伦比亚大学的副教授。他曾任
疾病控制和预防中心和加拿大政府的顾问，负责多
个国际项目。他还在泰国北部创立了一个非政府组
织——缅甸难民营。他的主要研究方向是评估重大
的社会政策对公众健康的影响，如儿童早期干预、
导向控制、住房和社会改革。他已发表了超过50篇
研究论文，并撰写了两本教科书。他的作品曾被
NPR, CNN, MSNBC引用并多次出现在各大平面媒体
，例如《纽约时报》和《Slate杂志》。
Professor Bijie HU, MD
Chief Physician, Zhongshan Hospital of Fudan
University
Dr. Chang earned his medical doctor degree from
Shanghai Medical University in 1984. He has worked in
clinical microbiology, lung infections, and hospital
infection control for over 20 years and published more
than 150 research papers. He has been the editor-inchief or vice editor-in-chief of 8 books, and co-editor of
28 books.
He is currently the Vice Director of Fudan University
Respiratory Diseases Research Center, and the Director
of the Infectious Diseases Department, Clinical
Microbiology Laboratory and Pneumology Department
of Zhongshan Hospital of Fudan University.
胡必杰 教授，医学博士
复旦大学附属中山医院主任医师
胡必杰教授1984年毕业于上海医科大学医学系，从
事临床微生物、肺部感染以及医院感染管理工作二
十余年。已发表学术论文150余篇。主编或合作主
编《医院感染学》、《下呼吸道感染实验室诊断规
范》、《医院感染预防与控制的标准操作规程》等
专著8部，参编28部。现任复旦大学呼吸病研究所
副所长、肺部感染研究室主任，复旦大学附属中山
医院感染性疾病科主任、医院感染管理科主任、临
床微生物实验室主任、呼吸科主任医师。
Professor Yuanzhi GUAN
Professor in Microbiology, Dean of
Department of Education Administration,
PUMC
Professor Guan earned his Master's Degree in
Medical Science at Chinese Academy of Medical
Sciences in 1981. He was a 1984-85 WHO fellow in
immunology and pathology at Geneva University
and 1986-88 DANIDA fellow in Microbiology at
Copenhagen University Hospital.
Professor Guan is editor of several medical journals
and co-author of 9 textbooks; his current research
interests include control of nosocomial infection and
bio-safety.
管远志 教授
协和医科大学教务处处长、医学微生物学教授
管远志于1981年从中国医学科学院基础医学研究所毕
业，获微生物及免疫学专业硕士学位。 1984至1985
年赴瑞士日内瓦大学医学院进修免疫； 1986－1988
年在丹麦哥本哈根大学医学院进修临床微生物学；并
曾在1996年在美国加州大学洛杉矶分校进修。
管远志教授现任协和医科大学教务处处长。他还是高
等医学教育学会理事，《中华儿科》杂志、《中华临
床免疫及变态反应》杂志以及《基础医学与临床》杂
志的编委会成员，曾参与编写多部教科书。管远志教
授的主要研究领域为：从靶细胞的跨膜信号传导途径
探讨致病性大肠杆菌感染的非抗生素治疗 ( nonantibiotic therapy )。
Michael GUSMANO, PhD
Associate Professor of Health Policy and Management,
New York Medical College ; Research Scholar, The
Hastings Center
Dr. Gusmano’s research interests include politics of health care
reform, comparative health systems, health and health care
inequalities, and normative theories of policy analysis. His most
recent book, Health Care in World Cities (Johns Hopkins
University Press, 2010), documents the implications of national
and local health care policies for access to care in New York,
London and Paris. He holds a Ph.D. in political science from the
University of Maryland at College Park and a Masters in public
policy from the State University of New York at Albany. He was
also post-doctoral fellow in the Robert Wood Johnson
Foundation Scholars in Health Policy program at Yale University
(1995-1997).
Dr. Gusmano is member of the Academy of Management, the
American Political Science Association (APSA), the American
Public Health Association, the Gerontological Society of America,
and the serves as the secretary of APSA’s Organized Section on
Health Politics and Policy. He is also on the editorial boards for
the Journal of Health Politics, Policy and Law and Health
Economics Policy and Law.
Michael GUSMANO，博士
纽约医学院卫生政策与管理副教授，美国黑斯
廷斯生物伦理学研究中心研究学者
Gusmano博士的研究兴趣包括医疗改革政策、比较卫生
系统、医疗和医保不平等以及政策分析的规范性理论。
他的最新著作《世界城市的卫生保健》（约翰霍普金斯
大学出版社，2010），记录了国家和地方性的医疗政策
在纽约、伦敦和巴黎的的影响。 他拥有美国马里兰大
学帕克分校的政治学博士学位，以及美国纽约州立大学
奥尔巴尼分校的公共政策硕士学位。 他还是耶鲁大学
罗伯特伍德约翰逊基金会学者卫生政策计划方向的博士
后(1995-1997) 。
Gusmano博士是 美国政治科学协会（APSA）管理学院
的成员，美国公共卫生协会成员， 美国老年学学会成
员，并且担任APSA卫生行政与政策小组的秘书官。 他
还是《卫生行政、政策和法律》杂志以及《卫生经济政
策和法律》杂志的编委会成员。
David GOLDFARB, MD
Director of Hemodialysis, New York
Veterans Affairs Medical Center; Chief of
Clinical Nephrology, NYU Langone Medical
Center; Professor of Medicine & Physiology,
NYU School of Medicine
Dr. Goldfarb’s research has involved all aspects of
chronic kidney disease and end stage kidney
disease, including anemia, hyperparathyroidism
and cardiovascular risk factors. He is also
internationally recognized for his research in
kidney stone pathophysiology and prevention.
David GOLDFARB，医学博士
纽约退休士兵医疗中心血液透析主任，纽
约大学Langone医疗中心临床肾脏病主任
，纽约大学医学院医学和生理学教授
Goldfarb教授的研究领域涉及慢性肾脏病和中
晚期肾脏病的各个领域，包括贫血症、甲状旁
腺功能亢进症和心血管疾病。他以在肾结石病
理生理学和预防方面的研究闻名国际。
Professor Yun-song YU, PhD
Assistant Dean and Director of Infectious Diseases, Sir
Run Run Shaw Hospital, College of Medicine, Zhejiang
University
Prof. Yu is mainly engaged in research on the surveillance of
bacterial resistance, the mechanism of bacterial resistance and
the treatment of infections caused by multi-resistant bacteria.
His work is supported by grants from the 973 Project, the 863
Project, and the National Nature Science Foundations of China
(NNSF). He won the second national prize for progress in science
and technology in 2007 and got the first and second prize for
progress in science and technology of Zhejiang province in 2003
and 2000.
Prof. Yu is Director of the Department of Infectious Diseases of
Sir Run Run Shaw Hospital, College of Medicine, Zhejiang
University. He is also Vice Director of the Clinical Microbial
Group of Chinese Microbial and Immune Association, Vice
Director of Zhejiang Microbial and Immune Association, and
editor of four medical journals.
俞云松 教授，博士
浙江大学医学院附属邵逸夫医院副院长、感染科主
任
俞云松教授现任浙江大学医学院附属邵逸夫医院副院长，
感染科主任，2005年获教育部新世纪优秀青年人才支持计
划基金（NCET-04-0552）资助，2007年获浙江省首届卫生
高层次创新人才计划资助，2008年入选浙江省新世纪151
人才工程第一层次 。俞教授长期从事传染科临床工作，
对感染性疾病，尤其是细菌感染性疾病的诊断和治疗有着
丰富的临床经验。1990年以来，一直从事细菌耐药机理、
耐药细菌感染及治疗的研究，以第一作者和通讯作者发表
SCI收录论文35篇。先后主持国家自然科学基金4项，主持
973子课题、863项目、卫生部行业基金各一项。
《JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY》、
《JOURNAL OF MEDICAL MICROBIOLOGY》等多家SCI论文审
稿人。
Professor Shan WANG, MD
President of Peking University People’s
Hospital, Professor of Surgery
Prof. WANG has devoted himself to clinical medicine
and hospital management. He has made significant
achievements in medical education, clinical and
basic medical research, modern hospital building
and management, health management and public
health promotion. He is a renowned surgeon as well
as a healthcare leader both in China and
internationally.
Prof. WANG graduated from Peking University in
1983 and did his research in tumor and trauma at
the University of Texas Medical Branch 1995-1998.
王衫 教授，医学博士
北京大学人民医院院长、北京大学外科学教授
王杉教授长期从事外科临床医疗实践与行业管理工
作，在临床医学教育、医学临床科研与基础研究、
现代医院建设与管理、健康管理以及公共医疗卫生
事业的促进与发展等多个专业领域，做出了突出的
成绩，在国内外享有较高的声誉。
王杉教授1983年毕业于北京医学院（现北京大学医
学部）医学系，1992年获医学博士学位。1995年—
1998年在美国德克萨斯大学医学院外科从事外科肿
瘤及创伤相关研究。
Laura L. FORESE, MD
Senior Vice President, Chief Medical Officer, Chief Operating Officer, New
York Presbyterian Hospital/Weill Cornell Medical Center
At New York Presbyterian, currently ranked #6 in US News among Best Hospitals, Dr.
Forese has responsibility for programs, operations and strategic direction for 1100
medical, surgical and psychiatric beds on two campuses.
Dr. Forese graduated summa cum laude, Phi Beta Kappa from Princeton University
and Alpha Omega Alpha from Columbia University College of Physicians & Surgeons.
A board-certified orthopaedic surgeon, she also holds a degree in health services
management from Columbia University School of Public Health.
After residency training at the Presbyterian Hospital in New York City, she assumed a
faculty position in the Department of Orthopaedic Surgery at Columbia University.
There she practiced pediatric orthopaedic surgery and held a series of management
roles; she was Vice Chair until she left to become a full time hospital executive in 2003.
Today, Dr. Forese has broad responsibility for the activities at NYP/WC that include day
to day operations as well as long range planning. Under her leadership, NYP/WC has
achieved significant improvements in efficiency, throughput, safety and patient and
employee satisfaction.
Through her membership in multiple professional organizations and societies, she is a
frequent speaker on management topics in medicine including communication skills,
risk management, quality, compliance and business integrity. She is currently
President Elect of the Chief Medical Officer Group at AAMC and is a member of the
NIH Taskforce on the Future of the Biomedical Workforce.
Dr. Forese is a Trustee of Princeton University and is active in community and
charitable organizations. She is married to Robert J. Downey, a thoracic surgeon; they
have twin daughters and a son.
Laura L. FORESE，医学博士
纽约长老会医院/Weill康奈尔医学中心（NYP/ WC）高
级副总裁、首席医疗官、首席运营官
Laura L. Forese是纽约长老会医院Weill 康奈尔医学中心（NYP/ WC）高级副总裁
、首席医疗官、首席运营官。纽约长老会医院是目前美国排名第六的医院，在
这里，Forese医生负责两个校区的大约1100个病床的运营管理工作。
Forese以优异成绩毕业于普林斯顿大学，并于哥伦比亚大学内科和外科学院获
得了医学博士学位。她是经过认证的骨科医生，并且拥有哥伦比亚大学公共卫
生学院的卫生服务管理学位。
经纽约长老会医院培训后，她承担起哥伦比亚大学骨科的教职。在那里，她从
事小儿骨科手术。与此同时，她还担任了一些管理职务，直到2003年离开哥伦
比亚大学成为全职的医院管理者。
Forese医生在NYP/ WC主要负责中心日常运营以及长远规划。在她的领导下，
NYP/ WC在提高医院效率、接待能力、安全性、病人和员工满意度方面均取得
了显著成效。
Forese医生是多个专业团体和协会的成员。她经常发表医学管理主题方面的演
讲，包括沟通技巧、风险管理、质量、合规性和业务完整性。她目前是美国医
学院协会（AAMC）首席医疗官小组的会长，并且是美国国立卫生研究院（NIH
）特别工作组成员。
Forese医生是普林斯顿大学的校董，活跃在各个社团和慈善机构。 她的丈夫是
胸外科医生 Robert j. Downey。他们育有一对双胞胎女儿和一个儿子。
Hufeng WANG, PhD
Director of Healthcare Reform and Development Center,
Deputy Director of Social Security Research Institute
WANG Hufeng, PhD Associate Professor, Deputy Director of Social Security
Research Institute, Director of Healthcare Reform and Development Center.
Professor Wang is responsible for the Masters in Public Administration
program on Health Policy and Management at Renmin University. He has
been instrumental in the development of the case studies that will be used
as the foundation of the International Healthcare Leadership certificate
course to be offered at Columbia University. Professor Wang’s research
focuses on Public Health and Health Promotional Policy; Pharmaceutical
Industrial Policy; Medical Security Policy; Public Hospital Reform; Social
Security Fund Investment and Regulation; Employee Welfare Plan. Last year
he traveled to three countries providing lectures on “Reform of China 's
Health Care System: Issues, Challenges, and the Future.”
Prior to his position at Renmin University, Professor worked for ten years in
the Hospital of Heibei Province as an administrator, held the position of
Deputy Director General, Deputy Director of Social Security Reform Working
Commission, responsible for “National Social Security System Pilot Testing at
the Social Security Bureau of Beihai, and served in the Ministry of Labour
and Social Security, Department of Medical Security involved in a series of
legislation drafting.
王虎峰，博士
医疗改革与发展研究中心主任、社会保障研究所副
所长
王虎峰， 博士，副教授，社会保障研究所副所长，中国人民大
学医改研究中心主任，MPA公共卫生与医疗政策研究方向责任教
授。王虎峰教授参与研究的案例，已被选入哥伦比亚大学的国
际医疗领袖证书课程。王教授的研究重点有：公共卫生与健康
促进政策，药品产业政策，医疗保障制度政策，公立医院改革
，社保基金投资和监管，员工福利计划等。他于去年在三个国
家举行演讲，演讲内容为《中国的医疗体制改革：问题，挑战
和前景》。
在调往人民大学工作前，王虎峰教授曾在河北省医院内从事了
十年管理工作；曾任广西北海市社保改革领导小组办公室副主
任、社会保险局副局长，负责“全国社会保障制度综合配套试
点”工作；曾在国家劳动和社会保障部医疗保险司工作，期间
参加了系列重要的法规文件起草工作。
David E. Wood
Managing Director, Healthcare and China & Hong Kong Healthcare
Leader, PricewaterhouseCoopers
David Wood has over 30-years of hospital administration and healthcare consulting
experience, both domestically in the United States, and internationally. He has served in
senior management positions with the University of California hospital system as assistant
director, the University of Colorado Hospitals as chief financial officer and director of
hospital operations and the Sydney Kimmel Cancer Research Center as senior vice president.
Internationally, he has served the Shakut Khanum Cancer Hospital and Research Center in
Pakistan as president, the United Family Hospitals in China as president and chief executive
officer and the New Century International Children’s Hospital in Beijing as president and
chief executive officer. In his role with the New Century International Children’s Hospital, he
was the only foreigner serving as president of a Chinese hospital.
His consulting work has included assisting clients in a variety of engagements
internationally including the United States, China, Germany, Vietnam, Greece, Austria,
England, Canada and Gambia. In China, Pakistan, Gambia and Vietnam, he undertook
hospital development activities and completed responsibility for oversight of the planning,
design, construction and opening of hospitals to include all space planning, operational
planning, strategic planning, financial forecasting, equipment and facility planning, work
flow development, IT master plan and implementation, strategic and operational budgeting,
development of staffing plan including all job descriptions and hiring of initial staff,
governance issues and initial strategic marketing activities. In his consulting activity in China,
Mr. Wood has assisted clients in engagements involving China market entry and strategic
development, market research and feasibility studies, operational efficiencies including
staffing, work flow analyses and medical staff development and due diligence reviews for
financing and acquisition purposes as well as market entry activity for numerous start-ups
and early-stage projects.
伍德威
普华永道医疗保健执行总监、中国和香港地区医疗行业
主管
伍德威先生拥有超过30年以上的医疗行业从业经验，先后在美国和世
界其它地区的众多医疗健康服务机构工作，如在美国加州大学医学部
担任助理主任、在科罗拉多大学附属医院担任财务总监及医院运营总
监、在悉尼金梅尔癌症研究中心任高级副总裁。在亚太地区，他历任
巴基斯坦Shakut Khanum癌症治疗和研究中心总裁，以及和睦家国际
医院的总裁和首席执行官。在他为北京新世纪国际儿童医院工作时，
伍德威先生是唯一一位在华担任中国医院院长的外国人。
伍德威先生的咨询客户遍布全球，业务范围多样，涉足的地区包括
中国、美国、英国、奥地利、德国、希腊、越南、冈比亚等地。他曾
在在中国, 巴基斯坦, 赞比亚和越南建立医院发展战略 ，其中包括对于
医院建立的整体规划，设计包括医院的空间规划，业务规划，战略规
划，财务预算，设备和设施规划， 工作流程发展，IT总体规划和实施
，战略和业务预算，人员编制发展规划其中包括职位描述，第一批员
工的聘用，管理问题和最初的战略营销策划。 在其中国的咨询业务
中，他帮助客户签订进入中国市场的协议并制定战略发展计划，进行
市场调查，可行性研究，并进行运营效率管理，包括人员配置，工作
流程分析和医务人员发展管理。对财务和收购计划以及许多项目初期
阶段进行审慎调查与评估.